Peter Joosten
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Multiple Myeloma Research and Treatments 5
- Chronic Myeloid Leukemia Treatments 2
- Oncology 6
- Cancer Treatment and Pharmacology 4
- Co-authors
- Hanneke C. Kluin‐Nelemans (5 shared papers)Cornelis A.M. van Bergen (2 shared papers)Ellie G.A. Lurvink (2 shared papers)Amon R. Wafelman (2 shared papers)J. E. Landegent (2 shared papers)J.H. Frederik Falkenburg (2 shared papers)Willem E. Fibbe (2 shared papers)Roel Willemze (2 shared papers)
- Journals
- Blood (7 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Hematological Oncology (1 paper)Quality of Life Research (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- NetherlandsSwitzerlandBelgium
In The Last Decade
Peter Joosten
19 papers receiving 523 citations
Peers
Comparison fields: 5 of 51
- Hematology 200
- Genetics 92
- Pathology and Forensic Medicine 132
- Immunology 158
- Oncology 184
Countries citing papers authored by Peter Joosten
This map shows the geographic impact of Peter Joosten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Joosten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Joosten more than expected).
Fields of papers citing papers by Peter Joosten
This network shows the impact of papers produced by Peter Joosten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Joosten. The network helps show where Peter Joosten may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Joosten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 226 | |
| 2 | 2014 | 70 | |
| 3 | 2013 | 45 | |
| 4 | 2015 | 38 | |
| 5 | 2017 | 32 | |
| 6 | 1999 | 30 | |
| 7 | 2014 | 17 | |
| 8 | 2003 | 17 | |
| 9 | 1999 | 13 | |
| 10 | Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon? | 1995 | 13 |
| 11 | Enteropathy-associated T-cell lymphoma presenting with eosinophilia. | 2003 | 10 |
| 12 | 2017 | 9 | |
| 13 | 2013 | 8 | |
| 14 | 2017 | 5 | |
| 15 | 2006 | 2 | |
| 16 | 2009 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2010 | 1 | |
| 19 | 2014 | 1 |
About Peter Joosten
Peter Joosten is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 19 papers that have together received 539 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Acute Lymphoblastic Leukemia research (4 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cancer therapeutics and mechanisms (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (200 citations), Genetics (92 citations), Pathology and Forensic Medicine (132 citations), Immunology (158 citations) and Oncology (184 citations). Peter Joosten has collaborated with scholars based in Netherlands, Switzerland and Belgium. Frequent co-authors include Hanneke C. Kluin‐Nelemans, Cornelis A.M. van Bergen, Ellie G.A. Lurvink, Amon R. Wafelman, J. E. Landegent, J.H. Frederik Falkenburg, Willem E. Fibbe, Roel Willemze, Willem M. Smit and Petra Kluck. Their work appears in journals such as Blood, Clinical Chemistry and Laboratory Medicine (CCLM), Hematological Oncology, Quality of Life Research and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.